Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation

por Olivera, Pável, Velásquez-Escandón, César, Campoy, Desirée, Flores, Katia, Canals, Tania, Johansson, Erik, Herranz, María José, Martínez, Laia, Cerezo-Manchado, Juan José, Salinas, Ramón
Publicado 2023

Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection

por Olivera, Pável E, Campoy, Desiree, Velasquez, César A, Flores, Katia, Canals, Tania, Johansson, Erik A, Martinez, Laia, Sierra, Jorge, Cerezo, Juan Jose, Salinas, Ramón
Publicado 2020